HAYLEY TEAGUE: Open Payments
NPI 1326521295 · CHEVY CHASE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,377 in 53 payments from 16 companies in 2025. Trend: 2023 $2,454 · 2024 $2,909 · 2025 $1,377
Food & beverage: $1,374Travel & lodging: $3
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $233 |
| UCB, Inc. | 4 | $186 |
| ABBVIE INC. | 9 | $141 |
| Novartis Pharmaceuticals Corporation | 4 | $112 |
| Regeneron Healthcare Solutions, Inc. | 3 | $102 |
| Janssen Biotech, Inc. | 4 | $99 |
| Incyte Corporation | 4 | $82 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $79 |
| Amgen Inc. | 3 | $79 |
| Galderma Laboratories, L.P. | 4 | $67 |
Products named: Bimzelx, EBGLYSS, SKYRIZI, TREMFYA, OPZELURA, Winlevi, OTEZLA, NEMLUVIO.
Industry payments across MD — which companies pay providers there.
